A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2.
Chi, X., Yan, R., Zhang, J., Zhang, G., Zhang, Y., Hao, M., Zhang, Z., Fan, P., Dong, Y., Yang, Y., Chen, Z., Guo, Y., Zhang, J., Li, Y., Song, X., Chen, Y., Xia, L., Fu, L., Hou, L., Xu, J., Yu, C., Li, J., Zhou, Q., Chen, W.(2020) Science 369: 650-655
- PubMed: 32571838 
- DOI: https://doi.org/10.1126/science.abc6952
- Primary Citation of Related Structures:  
7C2L - PubMed Abstract: 
Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding domain (RBD) of the Spike (S) protein but also across the full Spike (S) protein ...